eXroid® provides a non-surgical approach to haemorrhoid treatment using controlled electrotherapy. The treatment is designed for use by trained healthcare professionals and can be delivered in an appropriate clinical setting.
Our aim is to support healthcare professionals in providing patients with an alternative treatment pathway where eXroid® is clinically appropriate.
*Clinicians and patients can opt for anaesthesia as an elective choice, but it is not required when administering the treatment, enabling it to be performed in acute or primary care settings.
For practitioners the treatment is very simple and safe to perform, with instant visual benefit and symptom relief in almost all cases.
All practitioners are supported with device and clinical training. To apply to undertake the online clinical training programme and become proficient in the application of eXroid electrotherapy for the treatment of haemorrhoids please click here.
.png/:/)
eXroid Technology is now expanding globally as a result of its highly successful clinical treatment business in the UK. eXroid Technology is now available in Australia and New Zealand and expanding access to patients across both countries is a priority. We offer clinical training and support through the eXroid learning curve and also provide patient brochures and educational programs.
If you are interested in introducing the eXroid technology within your clinical practice across Australia or New Zealand, please don't hesitate to contact our eXroid Technology team.
If you have any questions then please don't hesitate to contact our team at eXroid Australia
Head Office: 18/310-312 Governor Road, Braeside VIC, 3195 Australia
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |
Copyright © 2026 exroid.com.au - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.